Cited by 41Grief, Bereavement, and Mental HealthSuicide and Self-Harm StudiesDeath, Funerary Practices, and Mourning

Treatment of Complicated Grief in Survivors of Suicide Loss: A HEAL Report

Zisook, Sidney, Shear, M. Katherine, Reynolds, Charles F., Simon, Naomi M., Mauro, Christine, Skritskaya, Natalia A., Lebowitz, Barry, Wang, Yuanjia +6 more·2018·The Journal of Clinical Psychiatry

Abstract

OBJECTIVE: Suffering associated with complicated grief (CG) is profound. Because suicide loss survivors are susceptible to developing CG, identifying effective treatments for suicide loss survivors with CG is a high priority. This report provides data on the acceptability and effectiveness of antidepressant medication and complicated grief therapy (CGT), a CG-targeted psychotherapy, for suicide loss survivors with CG identified by an Inventory of Complicated Grief score ≥ 30. METHODS: This is a secondary analysis of data collected from March 2010 to September 2014 for a 4-site, double-blind, placebo-controlled randomized trial comparing the effectiveness of antidepressant medication alone or in combination with CGT for participants with CG (score ≥ 30 on the Inventory of Complicated Grief) who were bereaved by suicide (SB; n = 58), accident/homicide (A/H; n = 74), or natural causes (NC; n = 263). Using mode of death as a grouping factor, we evaluated acceptability of treatments by comparing 12-week medication and 16-session CGT completion; we evaluated effectiveness by comparing response at week 20, defined by a score of 1 or 2 on the Complicated Grief Clinical Global Impressions-Improvement scale (CG-CGI-I), and additional secondary response measures. RESULTS: Among participants receiving medication alone, SB medication completion rates (36%) were lower than rates for A/H (54%) and NC (68%; χ² = 11.76, P < .01). SB medication completion rates were much higher for SB individuals receiving CGT (82%; χ² = 12.45, P < .001) than for SB individuals receiving medication alone. CGT completion rates were similar in the 3 groups (SB = 74%, A/H = 64%, NC = 77%; χ² = 2.48, P = .29). For SB participants receiving CGT, CG-CGI-I response rates were substantial (64%), but lower compared to the other groups (A/H = 93%, NC = 84%; χ² = 8.00, P < .05). However, on all other outcomes, changes from baseline for SB participants were comparable to those for A/H and NC participants, including number and severity of grief symptoms, suicidal ideation, and grief-related impairment, avoidance, and maladaptive beliefs. CONCLUSIONS: These results raise concern about the acceptability of medication alone as a treatment for complicated grief in treatment-seeking suicide-bereaved adults. In contrast, CGT is an acceptable and promising treatment for suicide-bereaved individuals with complicated grief. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT01179568.

Integrity signals

Registry

Crossref · 10.4088/jcp.17m11592

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cited by

Sorted by citations

Authors
Zisook, S., Shear, M. K., Reynolds, C. F., Simon, N. M., Mauro, C., Skritskaya, N. A., Lebowitz, B., Wang, Y., Tal, I., Glorioso, D., Wetherell, J. L., Iglewicz, A., Robinaugh, D., & Qiu, X.
Affiliations
  • University of California San Diego (US)
  • Columbia University (US)
  • University of Pittsburgh (US)
  • Harvard University (US)
  • VA San Diego Healthcare System (US)
  • Massachusetts General Hospital (US)
Venue
The Journal of Clinical Psychiatry
Published
2018-04-25
Volume
79
Issue
2
Pages
17m11592
ISSN
0160-6689 (ISSN-L)
OpenAlex
W2792473669
Cited by
41
References
0
Citations by year
2026: 3 · 2025: 9 · 2024: 6 · 2023: 6 · 2022: 2 · 2021: 6 · 2020: 6 · 2019: 3
FWCI
4.40
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Mental Health (R01MH085297, P30MH090333, R01MH085308, R01MH060783, R01MH085288)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Grief, Bereavement, and Mental Health
  • Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
  • Social Sciences › Anthropology › Death, Funerary Practices, and Mourning
Keywords
complicated grief, suicide loss survivors, antidepressants, treatment acceptability, bereavement, Inventory of Complicated Grief, suicidal ideation, grief symptoms, mode of death, maladaptive beliefs
MeSH terms
Adolescent, Adult, Aged, Aged, 80 and over, Antidepressive Agents, Combined Modality Therapy, Double-Blind Method, Grief, Humans, Middle Aged, Patient Acceptance of Health Care, Psychotherapy, Suicide, Outcome Assessment, Health Care, Survivors, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review